March 05, 2015 6:00 PM ET

Biotechnology

Company Overview of Aegera Therapeutics, Inc.

Company Overview

Aegera Therapeutics, Inc., a clinical stage biotechnology company, engages in developing targeted therapeutics to address unmet medical needs primarily in oncology and immuno-inflammation. The company focuses on developing AEG35156, a second generation antisense oligonucleotide that targets XIAP and is designed to lower the apoptotic threshold of cancer cells; and HGS1029, a small molecule inhibitor of apoptosis proteins (IAP), which is in clinical development stage for the treatment of a range of cancers. It also has various preclinical stage programs in the areas of oncology, autoimmune, inflammatory, and central nervous system diseases that include small molecule Bruton's tyrosine kinase ...

810 chemin du Golf

Montreal, QC H3E 1A8

Canada

Founded in 1997

Phone:

514-288-5532

Fax:

514-288-9280

Key Executives for Aegera Therapeutics, Inc.

Scientific Founder
Scientific Founder
Scientific Founder
Scientific Founder
Scientific Founder
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
IatroQuest Corporation Americas
DNA Testing Centers, Corp. Americas
Augurex Life Sciences Corp. Americas
Prognomix, Inc. Americas
IntelligentNano Inc. Americas

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Aegera Therapeutics, Inc., please visit www.aegera.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.